Breast Cancer News and Research

Latest Breast Cancer News and Research

Cancer patients getting unnecessary tests: Study

US researchers revealed that many cancer patients with only a few years to live often continue to get routine mammograms or blood tests for prostate cancer even though they are not likely to live long enough to benefit from them. This not only wastes money but also exposes patients to unnecessary worry and distress.

12 Oct 2010

Australian women stressed and overweight: Survey

In a poll known as “Australia's Biggest Health Check” 26,000 responders showed that Australia's women feel stressed out and unfit and overworked. It also shows that they have barely half an hour of leisure time per day and the mismatch between how much sex women want versus what they get. The survey was promoted via two magazines - Women's Health and Prevention - and also had the backing of Priceline and the Seven Network’s Sunrise program. There were 24,500 women and 1,500 men in on the poll.

12 Oct 2010

Rad51 protein plays a key role in DNA protection

Cancer Research UK scientists have shed new light on the vital role that a protein plays in protecting our DNA, reveals a study published in Nature Structural and Molecular Biology today.

12 Oct 2010

Engaging in healthy lifestyle can help women with family history control breast cancer risk

Having a family history of breast cancer can lead some women to wonder if the risk is out of their control. However, a study of more than 85,000 postmenopausal women, published in BioMed Central's open access journal Breast Cancer Research, observed that regular physical activity, maintaining a healthy weight, and drinking less alcohol lowers breast cancer risk for those with and without a family history of the disease.

12 Oct 2010

AACR announces recipients of Outstanding Investigator Award for Breast Cancer Research

The 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium will honor two leading breast cancer researchers during its meeting, which will be held Dec. 8-12 in the Henry B. Gonzales Convention Center, San Antonio, Texas. Klaus Pantel, M.D., Ph.D., is the recipient of the 2010 AACR Outstanding Investigator Award for Breast Cancer Research, funded by Susan G. Komen for the Cure.

12 Oct 2010

Racial disparities in breast cancer care persist despite health insurance and socioeconomic status

Racial disparities in the receipt of breast cancer care persist despite accounting for patients' insurance and social and economic status. That is the conclusion of a study published early online in Cancer, a peer-reviewed journal of the American Cancer Society. The findings suggest that greater efforts are needed to better understand disparities in breast cancer care and to ensure that all affected women receive equal and effective treatments.

12 Oct 2010

First presentation of anti-HER2 antibody-drug conjugate as first-line therapy for advanced breast cancer

A new type of breast cancer treatment has shown encouraging activity as a first-line therapy in HER2-positive metastatic disease, researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.

12 Oct 2010

Scripps Research study findings could transform drug development to produce more effective treatments

Scientists from The Scripps Research Institute have uncovered new evidence that challenges the current theory about a process key to the way modern drugs are designed and how they work in the human body.

12 Oct 2010

Healthy lifestyle can reduce breast cancer risk in women with family history

Having a family history of breast cancer can lead some people to wonder if their risk is out of their control. However, a study of more than 85,000 postmenopausal women observed that regular physical activity, maintaining a healthy weight, and drinking less alcohol lowers breast cancer risk for women with, and without a family history of the disease.

12 Oct 2010

Mammography, vaccines still raise questions in consumers' minds

NPR reports on two preventive measures that, despite years of research, still have consumers wondering what to do.

12 Oct 2010

Identifying subsets of patients who will respond to subsequent lines of chemotherapy

In a study presented at the 35th Congress of the European Society for Medical Oncology (ESMO), Dr Giovanni Bernardo from Fondazione Maugeri in Pavia, Italy, presented results that suggested it may be possible to identify subsets of metastatic breast cancer patients who are likely to respond to subsequent lines of chemotherapy.

11 Oct 2010

Adding Cetuximab to chemo doubles response rate in hard-to-treat breast cancer

European researchers have proven for the first time that targeting the epidermal growth factor receptor can provide substantial clinical benefit for women with hard-to-treat triple-negative breast cancer.

11 Oct 2010

Atomic Tattoos launches 'Tats for Tatas' breast cancer awareness fundraising campaign

Atomic Tattoos has announced the launch of their "Tats for Tatas" fundraising campaign that will take place throughout October, benefiting the Florida Breast Cancer Foundation in Florida and Southeast Regional Breast Cancer Fund in Wisconsin. In the company's concerted efforts to raise awareness and funds for Breast Cancer Awareness, Atomic Tattoos is offering several specials throughout the month if customers donate $5 to breast cancer awareness.

11 Oct 2010

Merck Serono announces first results from Erbitux BALI-1 study in metastatic triple-negative breast cancer

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced the first results from the BALI-1 study of Erbitux® (cetuximab) in the treatment of metastatic triple-negative breast cancer (TNBC), an aggressive cancer in which early relapse and metastasis are common. The data, presented during the 35th Congress of the European Society for Medical Oncology (ESMO), demonstrate that Erbitux has the potential to improve outcomes for women with this relentlessly devastating cancer.

11 Oct 2010

AVEO presents tivozanib Phase 2 study results at ESMO Congress

AVEO Pharmaceuticals, Inc. a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that previously reported results from its Phase 2 study evaluating tivozanib for the treatment of advanced renal cell carcinoma (RCC) were presented at the 35th European Society for Medical Oncology (ESMO) Congress in Milan, Italy.

11 Oct 2010

Researchers to convene for 2010 Advances in Breast Cancer Research Workshop at University of Arkansas

Leading national researchers in the fight against breast cancer will convene Oct. 26-29 for the 2010 Advances in Breast Cancer Research Workshop at the University of Arkansas. More than 70 scientists from diverse research areas in science, medicine, engineering and technology will participate. Ten featured speakers will present cutting-edge research on breast cancer diagnosis, therapeutic techniques, treatment and screening.

11 Oct 2010

Novel hormonal treatments may help ER-negative breast cancer patients: Study

Women who have estrogen (ER) negative breast cancer may have more drug treatment options than previously thought, a Creighton (pronounced Cray-ton) University study suggests. The study is reported in the Oct. 11 online version of the journal Oncogene.

11 Oct 2010

BioSante presents update on LibiGel clinical study at NAMS Annual Meeting

BioSante Pharmaceuticals, Inc. presented a LibiGel clinical study update at the 21st Annual Meeting of The North American Menopause Society (NAMS) on October 8, 2010, with more than 1,000 experts and practitioners in menopause and women's health in attendance.

11 Oct 2010

New natural dietary components inhibit breast cancer cells

Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer. The impressive results are found in the most recent publication of Integrative Cancer Therapies. Lead investigator Dr. Daniel Sliva says, The formula we studied inhibits growth of highly metastatic human breast cancer cells, and suppresses metastatic potential of these cells.

11 Oct 2010

Research-based tip sheets provide details on breast cancer

Throughout October, National Breast Cancer Awareness Month, experts from Fred Hutchinson Cancer Research Center and its clinical care partner, the Seattle Cancer Care Alliance, are offering a series of weekly research-based tip sheets regarding a variety of topics related to breast cancer, including breast cancer prevention, screening and early detection, treatment, and survivorship.

11 Oct 2010

Breast Cancer News and Research

Latest Breast Cancer News and Research

Cancer patients getting unnecessary tests: Study

Australian women stressed and overweight: Survey

Rad51 protein plays a key role in DNA protection

Engaging in healthy lifestyle can help women with family history control breast cancer risk

AACR announces recipients of Outstanding Investigator Award for Breast Cancer Research

Racial disparities in breast cancer care persist despite health insurance and socioeconomic status

First presentation of anti-HER2 antibody-drug conjugate as first-line therapy for advanced breast cancer

Scripps Research study findings could transform drug development to produce more effective treatments

Healthy lifestyle can reduce breast cancer risk in women with family history

Mammography, vaccines still raise questions in consumers' minds

Identifying subsets of patients who will respond to subsequent lines of chemotherapy

Adding Cetuximab to chemo doubles response rate in hard-to-treat breast cancer

Atomic Tattoos launches 'Tats for Tatas' breast cancer awareness fundraising campaign

Merck Serono announces first results from Erbitux BALI-1 study in metastatic triple-negative breast cancer

AVEO presents tivozanib Phase 2 study results at ESMO Congress

Researchers to convene for 2010 Advances in Breast Cancer Research Workshop at University of Arkansas

Novel hormonal treatments may help ER-negative breast cancer patients: Study

BioSante presents update on LibiGel clinical study at NAMS Annual Meeting

New natural dietary components inhibit breast cancer cells

Research-based tip sheets provide details on breast cancer

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in